Head-to-head comparison of non-invasive markers of atrial cardiomyopathy and their association with arrhythmia recurrence after atrial fibrillation ablation
Clinical Research in Cardiology · 2026-06 · 115 (6) · 1027-1041
DOI: 10.1007/s00392-026-02908-4 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Clinical Research in Cardiology, online erschienen am 30.03.2026. Verfasst von Laura Dippel und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology and Angiology, University Heart Center Freiburg-Bad Krozingen, Suedring 15, 79189, Bad Krozingen, Germany. Hauptthemen laut MEDLINE: Atrial Fibrillation, Catheter Ablation, Cardiomyopathies. Die Arbeit nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Universitäts-Herzzentrum Freiburg - Bad Krozingen GmbH.
Abstract (Originalsprache)
Background
Atrial cardiomyopathy (AtCM) represents an important substrate underlying atrial fibrillation (AF), increased arrhythmia recurrence after catheter ablation, and other adverse outcomes. Several non-invasive markers have been proposed as surrogates of AtCM, but their comparative performance and clinical relevance remain insufficiently validated.
Methods
In this retrospective study, 200 patients undergoing first-time catheter ablation for symptomatic AF were included. All patients underwent high-density left atrial electroanatomical mapping, which served as reference standard for AtCM assessment based on the extent of left atrial low-voltage substrate (LA-LVS). Non-invasive AtCM markers derived from 12-lead electrocardiography (ECG), transthoracic echocardiography, and blood-based biomarkers were systematically compared with LA-LVS extent and their predictive value for arrhythmia recurrence during follow-up was assessed.
Results
Among non-invasive AtCM markers, amplified P-wave duration (PWD) and P-wave amplitude in lead I showed the strongest association with LA-LVS extent. In multivariable logistic regression analysis, prolonged amplified PWD (≥ 150 ms) was independently associated with relevant AtCM (odds ratio 11.46, 95% confidence interval 2.27–57.90, p = 0.003). During a median follow-up of 277 days, arrhythmia recurrence occurred in 21.9% of patients. In Cox regression analysis, amplified PWD ≥ 150 ms was the only non-invasive AtCM marker independently associated with arrhythmia recurrence (hazard ratio 2.01, 95% confidence interval 1.07–3.78, p = 0.031).
Conclusion
In patients undergoing first-time AF ablation, amplified PWD emerged as the most robust non-invasive marker of AtCM, independently associated with invasively assessed LA-LVS and arrhythmia recurrence. Advanced surface ECG analysis may represent a practical and widely applicable tool for AtCM-associated risk stratification in routine clinical practice. Graphical abstract
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cardiology and Angiology, University Heart Center Freiburg-Bad Krozingen, Suedring 15, 79189, Bad Krozingen, Germany.
- Peter Osypka Institute for Medical Technology, Offenburg University of Applied Sciences, Badstrasse 24, 77652, Offenburg, Germany.
- Arrhythmia and Electrophysiology Section, Heart Center Lucerne, Lucerne Cantonal Hospital, Spitalstrasse 31, 6000, Lucerne, Switzerland.
- Department of Cardiology and Angiology, University Heart Center Freiburg-Bad Krozingen, Suedring 15, 79189, Bad Krozingen, Germany. martin.eichenlaub@uniklinik-freiburg.de.
Förderung
- Universitäts-Herzzentrum Freiburg - Bad Krozingen GmbH
Zitieren
APA
Dippel, L., Fedorov, D., Müller, J., Jadidi, A., Westermann, D., Lehrmann, H., Arentz, T., & Eichenlaub, M. (2026). Head-to-head comparison of non-invasive markers of atrial cardiomyopathy and their association with arrhythmia recurrence after atrial fibrillation ablation. Clinical Research in Cardiology, 115(6), 1027-1041. https://doi.org/10.1007/s00392-026-02908-4
Vancouver
Dippel L, Fedorov D, Müller J, Jadidi A, Westermann D, Lehrmann H, et al. Head-to-head comparison of non-invasive markers of atrial cardiomyopathy and their association with arrhythmia recurrence after atrial fibrillation ablation. Clinical Research in Cardiology. 2026;115(6):1027-1041. doi:10.1007/s00392-026-02908-4
BibTeX
@article{Dippel2026,
author = {Dippel, Laura and Fedorov, Denis and Müller, Julian and Jadidi, Amir and Westermann, Dirk and Lehrmann, Heiko and Arentz, Thomas and Eichenlaub, Martin},
title = {Head-to-head comparison of non-invasive markers of atrial cardiomyopathy and their association with arrhythmia recurrence after atrial fibrillation ablation},
journal = {Clinical Research in Cardiology},
year = {2026},
volume = {115},
number = {6},
pages = {1027--1041},
doi = {10.1007/s00392-026-02908-4}
}
EUVIMED